Stock A053030 BINEX CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company BINEX Co., Ltd.

Equities

A053030

KR7053030003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-13 EDT 		5-day change 1st Jan Change
15,660 KRW +11.22% Intraday chart for BINEX Co., Ltd. -2.12% +74.97%
03-15 BINEX Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-05 Singapore Stocks Linger in Red; IX Biopharma's Shares Soar 12% Following Unveiling of Novel Drug Delivery System MT

Business Summary

BINEX.CO.LTD is a Korea-based company mainly engaged in the manufacturing and distribution of pharmaceuticals. The Company’s products include digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as ointment, creams and others. It also manufactures bio medicines and raw materials. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 570

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
59.8 %
88,550 56.5 % 92,598 59.8 % +4.57%
Bio
40.2 %
68,115 43.5 % 62,227 40.2 % -8.64%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
87.6 %
130,464 83.3 % 135,659 87.6 % +3.98%
International
12.4 %
26,213 16.7 % 19,166 12.4 % -26.88%

Managers

Managers TitleAgeSince
Hyuk-Jong Lee CEO
 Chief Executive Officer 54 -
Myoung-Ho Jeong CHM
 Chairman 57 -
Myong-Chul Lee BRD
 Director/Board Member 65 -
Ji-Young Kim HRO
 Human Resources Officer 55 -
Jin-Sun Choi AUD
 Comptroller/Controller/Auditor 71 -

Members of the board

Members of the board TitleAgeSince
Hyuk-Jong Lee CEO
 Chief Executive Officer 54 -
Myoung-Ho Jeong CHM
 Chairman 57 -
Myong-Chul Lee BRD
 Director/Board Member 65 -
Jin-Sun Choi AUD
 Comptroller/Controller/Auditor 71 -
Sang-Cheol Jo BRD
 Director/Board Member 55 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 31,761,048 25,818,231 ( 81.29 %) 836,512 ( 2.634 %) 81.29 %

Shareholders

NameEquities%Valuation
Binex Holdings Co., Ltd.
9.443 %
2,999,117 9.443 % 30 M ₩
Kd Bio No1 Investment Association
3.778 %
1,200,000 3.778 % 12 M ₩
BINEX CO., LTD.
2.634 %
836,512 2.634 % 8 M ₩
KWANG DONG PHARMACEUTICAL CO., LTD.
1.228 %
390,000 1.228 % 4 M ₩
Myoung-Ho Jeong
1.216 %
386,288 1.216 % 4 M ₩
Hyuk-Jong Lee
0.4121 %
130,900 0.4121 % 1 M ₩
Myong-Chul Lee
0.1144 %
36,339 0.1144 % 368 359 ₩
Bong Su Seo
0.0567 %
18,000 0.0567 % 182 462 ₩
Dimensional Fund Advisors Ltd.
0.0429 %
13,619 0.0429 % 138 052 ₩
DFA Australia Ltd.
0.0246 %
7,823 0.0246 % 79 300 ₩

Holdings

NameEquities%Valuation
S.BIOMEDICS CO., LTD.
8.07%
 919,552 8.07% 22,687,739 $
BINEX CO., LTD.
2.63%
 836,512 2.63% 8,479,513 $
KWANG DONG PHARMACEUTICAL CO., LTD.
2.86%
 1,500,000 2.86% 7,412,640 $
NOILE-IMMUNE BIOTECH INC.
5.26%
 2,277,825 5.26% 2,344,907 $

Company contact information

BINEX Co., Ltd.

368-3 Dadae-ro Saha-gu

49469, Busan

+

http://www.bi-nex.com
address BINEX Co., Ltd.(A053030)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BINEX CO., LTD. Stock BINEX Co., Ltd.
+74.97% 355M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.60% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.42% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.02% 326B
ABBVIE INC. Stock AbbVie Inc.
+4.27% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.82% 239B
NOVARTIS AG Stock Novartis AG
+9.87% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-7.32% 200B
AMGEN INC. Stock Amgen Inc.
+8.12% 167B
PFIZER, INC. Stock Pfizer, Inc.
-1.42% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A053030 Stock
  4. Company BINEX Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW